{"filings":[{"id":2162476,"accession_number":"0001376474-26-000547","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2026-08-10T20:13:03+00:00","items":["5.07","5.02"],"status":"ready","headline":"NVE CEO Baker retires; Eames named president and CEO at annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Daniel A. Baker retired as president/CEO effective Aug 6, 2026; reelected to board and elected chairman.","Peter G. Eames elected to board and appointed president and CEO; succession was pre-announced June 22, 2026.","Carolyn W. Valentine newly elected to board; appointed to Compensation and Nominating/Corporate Governance committees.","Board expanded from five to seven directors with the elections of Eames and Valentine.","All seven directors elected; say-on-pay approved 3,011,073 for; auditor Boulay PLLP ratified 3,876,455 for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1802401,"accession_number":"0001376474-26-000513","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2026-07-22T20:05:03+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Corp Q1 revenue up 81% to $11.0M, EPS $1.32 vs $0.74, declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $11.0M (+81% YoY); product sales +82%, contract R&D +53%.","Net income $6.39M (+79%); diluted EPS $1.32 vs $0.74.","Quarterly dividend of $1.00/share, payable Aug 31, 2026 to holders of record Aug 3, 2026.","CEO cites new product sales and strong semiconductor market as growth drivers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1194877,"accession_number":"0001376474-26-000456","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2026-06-22T20:07:47+00:00","items":["5.02","8.01"],"status":"ready","headline":"NVE CEO Daniel Baker to retire Aug 6, 2026; Peter Eames named successor; board expands to 7","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Daniel Baker retires effective Aug 6, 2026; will remain Chairman if shareholders approve.","Peter Eames appointed President & CEO; base salary $260k plus performance plan tied to fiscal 2027 operating income.","Chairman Terry Glarner to step down but remain on Board; Carolyn Valentine nominated to Board, expanding from 5 to 7 directors.","Eames joined NVE in 2003, served as VP of Advanced Technology since 2016, leading R&D and production expansions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98522,"accession_number":"0001376474-26-000347","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q4 revenue up 5% to $7.65M, EPS $1.02; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $7.65M (+5% YoY); product sales up 6%, contract R&D down 19%.","Q4 net income $4.93M ($1.02 EPS) vs $3.89M ($0.80 EPS) in prior-year quarter.","Fiscal 2026 revenue $26.3M (+1.8%); net income $15.2M ($3.14 EPS) vs $15.1M ($3.11).","Quarterly dividend $1.00 per share, payable May 29, 2026 to holders of record May 18, 2026.","CEO cites strong revenue and earnings growth for second consecutive quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":3.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":26331218.0,"consensus_period":"2026-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114056,"accession_number":"0001376474-26-000058","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2026-01-21T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE reports Q3 revenue up 23% to $6.22M, EPS $0.70 (+11% YoY); declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $6.22M, up 23% from $5.06M; product sales +16%, contract R&D +335%.","Net income $3.38M ($0.70 diluted EPS) vs $3.05M ($0.63) prior-year quarter.","First nine months revenue $18.7M (+0.4%); net income $10.3M ($2.12 EPS), down 8% YoY.","Quarterly dividend of $1.00 per share payable Feb 27, 2026 to holders of record Feb 2, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":2.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":18676412.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130447,"accession_number":"0001376474-25-000978","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2025-12-17T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE extends Abbott supply agreement through 2027 with pricing increases for 2026-2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment No. 12 to Supplier Partnering Agreement with Pacesetter (Abbott) executed Dec 12, 2025.","Term extended through December 31, 2027; pricing for 2026 and 2027 increased (amounts redacted).","Parties agree to work on stabilizing costs and aligning pricing beyond 2027.","Agreement governs supply of sensor products; Abbott is a key customer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130448,"accession_number":"0001376474-25-000856","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2025-10-22T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q2 revenue down 6% to $6.35M; EPS $0.68 vs $0.83; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $6.35M, down 6% YoY; product sales +1%, contract R&D -68%.","Net income $3.31M ($0.68 diluted EPS) vs $4.03M ($0.83) in prior-year quarter.","Board approves quarterly dividend of $1.00/share, payable Nov 28 to holders of record Nov 3.","CEO cites 4% sequential revenue increase driven by distributor and non-defense sales.","First-half FY2026 revenue $12.5M (-8% YoY); net income $6.89M ($1.42 EPS) vs $8.12M ($1.68)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":12451636.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147010,"accession_number":"0001376474-25-000737","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2025-08-12T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"NVE shareholders elect all five director nominees and approve executive pay and auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All five director nominees elected: Glarner, Baker, Hollister, Bracke, Wei each received >2.98M votes with minimal withhold.","Advisory vote on named executive officer compensation passed: 3,171,573 for, 87,852 against, 10,637 abstain.","Ratification of Boulay PLLP as auditor for FY ending March 2026 passed: 3,871,548 for, 2,794 against, 11,171 abstain.","Meeting had quorum with 4,837,166 shares represented; all incumbent directors attended."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147009,"accession_number":"0001376474-25-000657","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q1 revenue down 10% to $6.10M; EPS $0.74 vs $0.85; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $6.10M (down 10% YoY), net income $3.58M (down 13%); diluted EPS $0.74.","Product sales fell 11%, partially offset by 17% increase in contract R&D revenue.","Quarterly dividend of $1.00/share, payable Aug 29, 2025 to holders of record Aug 4, 2025.","CEO cites strong revenue and earnings despite decrease in defense product sales."],"consensus_eps_estimate":null,"consensus_eps_actual":0.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":6104644.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165519,"accession_number":"0001376474-25-000436","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q4 revenue up 3% to $7.27M, EPS $0.80; full-year revenue down 13%; $1.00 dividend declared","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $7.27M (+3% YoY); net income $3.89M ($0.80 EPS) vs $3.81M ($0.79).","Full-year FY2025 revenue $25.9M (-13% YoY); net income $15.1M ($3.11 EPS) vs $17.1M ($3.54).","Q4 product sales -1% YoY, but contract R&D revenue surged 558% offsetting decline.","Quarterly dividend of $1.00/share declared, payable May 30, 2025 to holders of record May 19, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":3.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":25874694.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183159,"accession_number":"0001376474-25-000205","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2025-02-13T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE extends supply agreement with Abbott through Dec 2025; 2025 price increases on three part numbers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment No. 11 extends Supplier Partnering Agreement term to December 31, 2025.","Pricing increases for three part numbers (1071000-001, 100101124, 100127071) effective for shipments after Dec 31, 2024; specific prices redacted as confidential.","New Section 10.9 adds trade controls representations and warranties regarding sanctions, sanctioned areas, and sub-supplier compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183160,"accession_number":"0001376474-25-000100","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2025-01-22T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q3 revenue down 25% to $5.06M, net income falls 27% to $0.63 EPS; $1.00 dividend declared","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $5.06M, down 25% YoY; product sales fell 22% and contract R&D revenue dropped 74%.","Q3 net income $3.05M ($0.63 diluted EPS), vs $4.18M ($0.87 EPS) a year ago.","First nine months revenue $18.6M (-18% YoY); net income $11.2M ($2.31 EPS), down 16%.","Board approved $1.00 per share quarterly dividend, payable Feb 28, 2025 to holders of record Feb 3, 2025.","CEO Dan Baker cited challenging industry conditions for the sales decline."],"consensus_eps_estimate":null,"consensus_eps_actual":2.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":18604979.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199731,"accession_number":"0001376474-24-000647","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2024-11-07T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE extends office/manufacturing lease to May 2031 with escalating rent","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Lease extended 62 months, new expiration May 31, 2031 (originally March 31, 2026).","Monthly base rent rises from $15,416.24 to $17,214.21 on April 1, 2026, with annual increases.","Free base rent granted for April and May 2026.","$100,000 improvement allowance from landlord, subject to conditions and completion deadlines.","Tenant has option to extend lease five more years; must exercise by June 30, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199732,"accession_number":"0001376474-24-000613","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q2 revenue down 5% to $6.76M; EPS $0.83 vs $0.98; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue for Q2 FY2025: $6.76M, down 5% from $7.13M; product sales fell 14%, contract R&D surged 3,950%.","Net income for Q2: $4.03M ($0.83 diluted EPS) vs $4.72M ($0.98) prior year, down 15%.","First-half FY2025 revenue: $13.5M (down 15%); net income $8.12M ($1.68 EPS) vs $9.13M ($1.89).","Board declared quarterly cash dividend of $1.00 per share, payable Nov 29, 2024 to holders of record Nov 4, 2024.","CEO cited 'solid earnings despite slow industry recovery'; stock ticker NVEC listed on Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":13541934.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215751,"accession_number":"0001376474-24-000393","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"NVE shareholders elect all five directors, approve say-on-pay, ratify auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All five director nominees elected: Glarner (2.78M for), Baker (3.06M), Hollister (2.85M), Bracke (3.05M), Wei (3.06M).","Advisory vote on named executive officer compensation passed: 3,015,808 for, 89,586 against.","Boulay PLLP ratified as auditor for FY ending March 2025: 3,759,285 for, 6,099 against.","Total shares entitled to vote: 4,833,676; majority represented at meeting.","No solicitation in opposition; all incumbent directors attended."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215750,"accession_number":"0001376474-24-000322","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE reports Q1 revenue down 23% to $6.78M, EPS $0.85 vs $0.91 prior year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $6.78M, down 23% YoY; product sales fell 24%, contract R&D up 28%.","Net income $4.10M ($0.85 diluted EPS) vs $4.40M ($0.91) prior year, down 7%.","Board approved $1.00 per share quarterly dividend, payable Aug 30, record July 29.","CEO cites solid earnings despite challenging industry environment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.85,"consensus_revenue_estimate":null,"consensus_revenue_actual":6783244.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235163,"accession_number":"0001376474-24-000235","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"NVE director Richard Kramp dies; Dr. Kelly Wei elected to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Richard W. Kramp passed away May 2, 2024 after an illness; served on NVE board since 2014.","Dr. Kelly Wei elected to board effective May 13, 2024 to fill unexpired term ending at 2024 annual meeting.","Wei is VP of Corporate Strategy at Medtronic, appointed to Compensation and Nominating committees.","Board determined Wei is independent under NASDAQ Listing Rule 5605(a)(2) and SEC regulations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235162,"accession_number":"0001376474-24-000213","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q4 revenue $7.08M (-45%), EPS $0.79; FY revenue $29.8M (-22%); declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $7.08M (-45% YoY); net income $3.81M ($0.79 EPS) down 54%.","FY2024 revenue $29.8M (-22% YoY); net income $17.1M ($3.54 EPS) down 25%.","Product sales fell 21% in FY; contract R&D revenue decreased 45%.","$1.00/share dividend approved; payable May 31, 2024, record May 13, 2024.","CEO says solid earnings despite semiconductor industry downturn."],"consensus_eps_estimate":null,"consensus_eps_actual":3.54,"consensus_revenue_estimate":null,"consensus_revenue_actual":29804179.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252981,"accession_number":"0001376474-24-000039","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2024-01-17T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q3 revenue down 9% to $6.76M; net income down 1% to $4.18M; declares $1/share dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue for quarter ended Dec 31, 2023: $6.76M, down 9% vs $7.40M prior year. Product sales down 12%; contract R&D up 94%.","Net income $4.18M ($0.87 EPS) vs $4.23M ($0.88 EPS) prior year.","Nine-month revenue $22.7M (down 11%); net income $13.3M ($2.75 EPS) vs $14.5M ($2.99 EPS).","Quarterly cash dividend of $1.00 per share, payable Feb 28, 2024 to holders of record Jan 29, 2024.","CEO cites decrease in defense-related product sales and semiconductor downturn."],"consensus_eps_estimate":null,"consensus_eps_actual":2.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":22720950.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252980,"accession_number":"0001376474-24-000002","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2024-01-03T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE extends Abbott supply pact through Dec 2024 with price increases","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment No. 10 extends Supplier Partnering Agreement with Abbott subsidiary Pacesetter through December 31, 2024.","Pricing increased for three part numbers (1071000-001, 100101124, 100127071) effective for shipments after Dec 31, 2023; specific amounts redacted.","Amendment dated December 7, 2023, fully executed and received by NVE on January 2, 2024.","Agreement originally effective Jan 1, 2006; Amendment No. 10 supersedes certain prior amendments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":270456,"accession_number":"0001753926-23-001368","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2023-10-18T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q2 revenue falls 33% to $7.13M; EPS drops to $0.98 from $1.26; $1.00 dividend declared","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue for Q2 FY2024 was $7.13M, down 33% from $10.7M YoY; product sales down 32%, contract R&D down 92%.","Net income for Q2 was $4.72M ($0.98 diluted EPS) vs $6.09M ($1.26 EPS) in prior-year quarter.","For H1 FY2024, total revenue $16.0M (-12% YoY), net income $9.13M ($1.89 EPS) vs $10.2M ($2.12 EPS).","Board declared a $1.00/share quarterly cash dividend, payable Nov 30, 2023 to holders of record Oct 30, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":15964690.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287408,"accession_number":"0001376474-23-000395","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2023-08-07T23:59:59+00:00","items":["5.03","5.07"],"status":"ready","headline":"NVE Corp amends bylaws for majority voting; shareholders reelect directors and approve proposals","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bylaws amended to require majority vote in uncontested director elections, replacing plurality standard.","Annual meeting: all five incumbent directors reelected; Terrence Glarner had 2,436,182 votes for and 452,886 withheld.","Shareholders approved named executive officer compensation (2,747,800 for, 91,382 against) and favored annual say-on-pay.","Auditor Boulay PLLP ratified for fiscal 2024 with 3,635,666 votes for, 8,075 against, 12,893 abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287407,"accession_number":"0001376474-23-000367","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2023-07-19T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q1 revenue up 20% to $8.83M, net income up 6%, declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $8.83M for June quarter, up 20% YoY; product sales up 23%.","Net income $4.40M ($0.91 EPS diluted), up 6% from $4.14M ($0.86) prior year.","Board declares $1.00/share quarterly dividend, payable Aug 31, record Jul 31.","Contract R&D revenue decreased 50% YoY, partially offsetting product sales growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":8831414.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287406,"accession_number":"0001376474-23-000366","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2023-07-19T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE Corp amends 2015 supply agreement with Sonova AG on pricing, payment terms, lead time","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Second Amendment to 2015 Supply Agreement with Sonova AG effective July 17, 2023.","Amendment modifies pricing table in Appendix B, payment terms in Section 10.4, and standard lead time; specific figures redacted.","Payment conditions changed to ** after invoice; Sonova may withhold payment for quality breaches per amended Section 10.4.","Standard Product lead time changed to ** from receipt of order.","All other terms of 2015 Supply Agreement and First Amendment remain in full force and effect."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307555,"accession_number":"0001376474-23-000286","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"NVE Corp CFO Joseph Schmitz resigns; Daniel Nelson named Principal Financial Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph R. Schmitz resigned as CFO effective May 5, 2023.","Daniel Nelson, age 37, appointed Accounting Manager and Principal Financial Officer.","Nelson joined NVE in Sep 2022; previously at RMH Tax & Business Advisors and Intelligere.","Nelson holds Bachelor's and Master's in Accounting from University of Liberia; started career at Baker Tilly Liberia.","Nelson signed non-compete, confidentiality, and invention assignment agreement; eligible for performance-based compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":307554,"accession_number":"0001376474-23-000282","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2023-05-03T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Corp Q4 rev +91% to $12.8M, EPS $1.70; FY net income record $22.7M; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenue $12.8M, up 91% YoY; net income $8.23M ($1.70 diluted EPS), up 116%.","Fiscal 2023 revenue $38.3M (+42% YoY); net income record $22.7M ($4.70 diluted EPS), +56%.","Product sales increased 95% in Q4 and 44% for the year; contract R&D revenue +10% in Q4.","Quarterly dividend of $1.00/share declared, payable May 31, 2023 to holders of record May 15, 2023.","CEO cites 'record revenue and earnings' for the quarter and fiscal year."],"consensus_eps_estimate":null,"consensus_eps_actual":4.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":38253592.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326560,"accession_number":"0001376474-23-000056","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2023-01-25T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q3 rev $7.4M (+18% YoY), EPS $0.88 (+22%); declares $1.00/share dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue increased 18% to $7.40M; product sales up 22% YoY.","Net income $4.23M ($0.88 diluted EPS) vs $3.47M ($0.72) in prior-year quarter.","Nine-month revenue $25.5M (+26%); net income $14.5M ($2.99 EPS) vs $10.7M ($2.21).","Board declared $1.00 quarterly cash dividend, payable Feb 28, 2023, record Jan 30, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":2.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":25455909.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326559,"accession_number":"0001376474-23-000055","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2023-01-25T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE extends Abbott supplier pact to Dec 2023, raises prices on three parts","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Amendment No. 9 extends the Supplier Partnering Agreement through Dec 31, 2023; prior term had expired.","Pricing increased for three part numbers: 1071000-001, 100101124, and 100127071; specific amounts redacted.","Price adjustments apply to all shipments after Jan 11, 2023.","NVE supplies sensor products to Abbott subsidiary Pacesetter under this long-term agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344279,"accession_number":"0000724910-22-000031","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2022-10-19T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE reports Q2 revenue up 57% to $10.7M, EPS $1.26 vs $0.75","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue for Q2 FY2023 increased 57% to $10.7M from $6.82M.","Net income increased 67% to $6.09M ($1.26 per diluted share) from $3.65M ($0.75).","First-half revenue rose 29% to $18.1M; net income up 42% to $10.2M ($2.12 per diluted share).","Board declared quarterly dividend of $1.00 per share, payable Nov 30, 2022 to holders of record Oct 31, 2022.","Product sales up 59% in Q2; contract R&D revenue up 5% in Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":2.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":18054231.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360781,"accession_number":"0000724910-22-000023","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2022-08-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"NVE shareholders elect all five directors and approve executive pay at 2022 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected directors: Terrence W. Glarner (3,066,755 for, 389,986 withheld), Daniel A. Baker, Patricia M. Hollister, Richard W. Kramp, James W. Bracke.","Advisory approval of named executive officer compensation passed with 3,417,503 for, 11,416 against, 27,820 abstentions.","Ratification of Boulay PLLP as independent auditor for FY ending March 31, 2023 approved with 4,064,026 for, 28,853 against, 4,239 abstentions.","A majority of shares represented at meeting; all proposals carried as recommended by the board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360780,"accession_number":"0000724910-22-000021","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2022-07-20T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q1 FY2023 revenue up 3% to $7.34M; net income +16% to $0.86 diluted EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.34M (+3% YoY); net income $4.14M ($0.86 EPS) vs $3.58M ($0.74 EPS) in prior-year quarter.","Board approves $1.00/share quarterly cash dividend payable Aug 31, 2022 to holders of record Aug 1, 2022.","CEO Daniel Baker cites strong earnings growth for the quarter.","No guidance or outlook provided in the release."],"consensus_eps_estimate":null,"consensus_eps_actual":0.86,"consensus_revenue_estimate":null,"consensus_revenue_actual":7336407.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379897,"accession_number":"0000724910-22-000009","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2022-05-04T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q4 revenue up 15% to $6.72M; EPS $0.79 vs $0.65 YoY; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenue $6.72M (+15% YoY); product sales +12%, contract R&D +104%.","Q4 net income $3.82M ($0.79 diluted EPS) vs $3.13M ($0.65) in prior year.","FY 2022 revenue $27.0M (+26% YoY); net income $14.5M ($3.00 EPS) vs $11.7M ($2.42).","Board approved $1.00/share quarterly dividend payable May 31, 2022 to holders of record May 16, 2022.","CEO cited strong growth despite industry supply-chain disruptions."],"consensus_eps_estimate":null,"consensus_eps_actual":3.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":26986970.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398050,"accession_number":"0000724910-22-000006","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K/A","filed_at":"2022-02-02T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"NVE extends Abbott supplier agreement through Dec 2022; pricing amended","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Executed Amendment No. 8 to Supplier Partnering Agreement with Abbott on Feb 1, 2022.","Term extended through December 31, 2022; pricing terms amended.","Confidential portions redacted; company will furnish unredacted copy to SEC upon request."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398052,"accession_number":"0000724910-22-000004","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2022-01-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"NVE appoints Joseph R. Schmitz as CFO effective January 20, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph R. Schmitz, age 59, appointed CFO; previously management roles at Trane Technologies.","Annual salary of $195,000; eligible for performance-based compensation of $10,000 in May 2022 and target 20%-25% of salary.","Schmitz has MBA from Indiana University, B.S.B. in Accounting from U of Minnesota, CPA (inactive) and CMA.","He signed agreement with non-competition, confidentiality, and assignment of invention provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398051,"accession_number":"0000724910-22-000003","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2022-01-19T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE Q3 revenue down 4% to $6.29M; EPS $0.72 vs $0.81; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $6.29M, down 4% YoY; product sales down 7%, contract R&D up 86%.","Net income $3.47M ($0.72 diluted EPS) versus $3.93M ($0.81) in prior-year quarter.","Nine-month revenue $20.3M (+31% YoY), net income $10.7M ($2.21 diluted EPS) vs $8.56M ($1.77).","Quarterly cash dividend of $1.00/share declared, payable Feb 28, 2022 to holders of record Jan 31, 2022.","CEO cites supply-chain disruptions delaying product shipments; work-in-process inventories strong."],"consensus_eps_estimate":null,"consensus_eps_actual":2.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":20267433.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":417047,"accession_number":"0000724910-21-000036","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2021-12-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"NVE Corporate Controller and PFO Jon Larson resigns effective Jan 3; CEO Baker interim","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jon J. Larson resigned as Corporate Controller and Principal Financial Officer, effective January 3, 2022.","President and CEO Daniel A. Baker appointed as interim Principal Financial Officer.","No reason for resignation provided; departure effective less than one month from filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":417046,"accession_number":"0000724910-21-000034","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2021-10-20T23:59:59+00:00","items":["2.02","8.01"],"status":"ready","headline":"NVE reports Q2 revenue up 56% to $6.82M; EPS $0.75 vs $0.46; declares $1.00 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 total revenue $6.82M (+56% YoY); net income $3.65M (+64%); diluted EPS $0.75 vs $0.46.","Six-month revenue $14.0M (+56%); net income $7.23M (+56%); EPS $1.49 vs $0.96.","Product sales grew 59% in Q2 and H1; contract R&D revenue declined 13%.","Quarterly cash dividend of $1.00/share declared, payable Nov 30, 2021 to holders of record Nov 1, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":1.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":13976625.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":417045,"accession_number":"0000724910-21-000031","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2021-10-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"NVE CFO Curt Reynders retires Oct 1; Jon Larson appointed Principal Financial Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Curt A. Reynders retired as CFO on October 1, 2021, as previously disclosed in July.","Jon J. Larson, age 36, appointed Principal Financial Officer effective Oct 1.","Larson had been Corporate Controller since Sept 20, 2021; holds CPA, MBA.","Annual salary of $150,000; eligible for performance-based compensation of $5,000 in May 2022.","Agreement includes non-competition, confidentiality, and invention assignment provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":434615,"accession_number":"0000724910-21-000023","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2021-08-09T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"NVE annual meeting elects new director James W. Bracke; all proposals pass","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gary R. Maharaj did not stand for reelection, term expired Aug 5, 2021; James W. Bracke elected to board.","All five director nominees elected: Glarner, Baker, Hollister, Kramp, Bracke (highest votes: Bracke 3,362,943; lowest Glarner 2,998,535).","Advisory approval of executive compensation passed: 3,349,287 for, 11,416 against, 27,816 abstain.","Ratification of auditor Boulay PLLP passed: 3,995,810 for, 28,853 against, 4,235 abstain.","4,833,232 shares entitled to vote, majority represented at meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":434614,"accession_number":"0000724910-21-000021","cik":724910,"company_name":"NVE CORP /NEW/","ticker":"NVEC","form_type":"8-K","filed_at":"2021-07-21T23:59:59+00:00","items":["2.02","5.02","8.01"],"status":"ready","headline":"NVE reports Q1 revenue $7.15M (+56%), EPS $0.74; CFO to retire; $1 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $7.15M, up 56% YoY; product sales up 60% to $6.95M.","Net income $3.58M ($0.74 diluted EPS) vs. $2.41M ($0.50) prior year.","CFO Curt A. Reynders to retire effective Oct 1, 2021.","Quarterly dividend of $1.00 per share payable Aug 31, 2021 to holders of record Aug 2."],"consensus_eps_estimate":null,"consensus_eps_actual":0.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":7153163.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":455806146.1810666,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}